PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v8i3.7228ArticleResearch Progress on the Association Between Gut Microbiota and Respiratory System Diseaseshttps://artdesignp.com/journal/PAR/8/3/10.26689/par.v8i3.7228LiuJing,SunRuilin2024832024-06-19This paper aims to review the association between gut microbiota and respiratory system diseases, and explore their potential mechanisms and clinical significance. Gut microbiota, as an important microbial ecosystem in the human body, has profound effects on host health. Recent studies have shown that the imbalance of gut microbiota is closely related to the occurrence and development of respiratory system diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pneumonia. We comprehensively analyzed the current research progress and found that gut microbiota may affect respiratory system diseases through various pathways, including immune regulation, inflammatory responses, and airway mucus secretion. Additionally, environmental factors, lifestyle, and dietary habits are also closely related to gut microbiota and respiratory system health. Understanding the relationship between gut microbiota and respiratory system diseases not only helps to reveal the mechanisms of disease occurrence but also provides a theoretical basis for the development of new treatment strategies. Future research should focus on exploring the types and functions of gut microbiota, conducting clinical trials based on this, investigating the effects of gut microbiota modulation on the treatment and prevention of respiratory system diseases, and providing new directions for personalized medicine.

He H, He H, Mo L, et al., 2024, Gut Microbiota Regulate Stress Resistance by Influencing Microglia-Neuron Interactions in the Hippocampus. Brain, Behavior, Immunity - Health, (36): 100729.

Shi Z, Li X, Chen J, et al., 2024, Enzyme-Like Biomimetic Oral-Agent Enabling Modulating Gut Microbiota and Restoring Redox Homeostasis to Treat Inflammatory Bowel Disease. Bioactive Materials, (35): 167–180.

Yao X, Zhang R, Wang X, 2024, The Gut-Joint Axis: Genetic Evidence for a Causal Association Between Gut Microbiota and Seropositive Rheumatoid Arthritis and Seronegative Rheumatoid Arthritis. Medicine, 103(8): e37049–e37049.

Duan X, Zhang L, Liao Y, et al., 2024, Semaglutide Alleviates Gut Microbiota Dysbiosis Induced by a High-Fat Diet. European Journal of Pharmacology, (696): 176440.

Lyu X, Zhang TT, Ye Z, et al., 2024, Astragaloside IV Mitigated Diabetic Nephropathy by Restructuring Intestinal Microflora and Ferroptosis. Molecular Nutrition Food Research, 68(6): e2300734.

Yu Y, Zeng F, Han P, et al., 2024, Dietary Chlorogenic Acid Alleviates High-Fat Diet-Induced Steatotic Liver Disease by Regulating Metabolites and Gut Microbiota. International Journal of Food Sciences and Nutrition, 75(4): 369–384.

Zhang Y, Dong L, Dai X, et al., 2024, Modulation of Intestinal Metabolites by Calorie Restriction and Its Association with Gut Microbiota in a Xenograft Model of Colorectal Cancer. Discover. Oncology, 15(1): 46.

Vilarrubias BC, Pérez RM, Almela LI, et al., 2024, Nav1.8-Expressing Neurons Control Daily Oscillations of Food Intake, Body Weight and Gut Microbiota in Mice. Communications Biology, 7(1): 219.

Tao H, Wang CR, Guo JC, et al., 2020, Research Progress on the Relationship Between Intestinal Flora and Mental and Psychological Diseases. Advances in Microbiology, 10(6): 295–305.

Chen Q, Jiang J, 2017, Relationship Between Functional Constipation and Brain-Gut-Microbiota Axis. Zhonghua Wei Chang Wai Ke Za Zhi, 20(12): 1345–1347.